LQDA - Liquidia Quarterly EPS earnings growth

Official company branding of Liquidia Corporation (LQDA)

Despite the risks of supply chain disruptions caused by global instability, Liquidia Corporation (LQDA) maintains its status as a reputable developer of pulmonary hypertension therapy systems. The volatility of the quarterly EPS clearly demonstrates profit dynamics, where -6331.00 shapes the current metric. The business focus is currently shifted toward the rollout of Yutrepia through the optimization of drug delivery methods and the resolution of patent disputes.

Liquidia (LQDA) Year-over-year earnings per one share growth for the last 12 months: for the period 07/04/2022 - 11/17/2026

Summary analytical data breakdowns for liquidia.com (LQDA)

- share price and expert price forecast:
Fundamental company analysis:Liquidia Corp, LQDA
Flagship merchandise of Liquidia Corporation

This metric tracks net income per share dynamics compared to the same quarter last year. This growth rate determines the efficiency of business capitalization and its investment attractiveness. At Liquidia Corporation (LQDA), the precision of the PRINT platform reduces manual labor costs, directly impacting profitability. The effect of automated formulations is reflected in the financial statements. By analyzing this quarterly earnings per share chart, investors can distinguish overvalued assets from fundamentally strong ones.

Competitor analysis

HLN: Quarterly EPS earnings growth|Kenvue Corp - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma PLC) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months jyongbio.com MENS|Year-over-year earnings per share growth for the last twelve months Ligand (LGND)|AMRX (Amneal) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Perrigo PRGO|Quarterly EPS earnings growth Alvotech Biopharmaceuticals ALVO|Galapagos Corp - Quarterly EPS earnings growth|ANIP (ANI Pharmaceuticals) - Year-over-year earnings per share growth for the last 12 months|MannKind Corp. (MNKD) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Corp) - Quarterly EPS earnings growth|SPRY: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth TBPH|Year-over-year net earnings per share change for the last twelve months Aquestive Therapeutics, Inc.|Year-over-year earnings per share growth for the last twelve months scPharmaceuticals Inc. SCPH|TECX: Year-over-year earnings per share growth for the last 12 months|TNXP - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months SXT Pharmaceuticals SXTC|EPRX: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months bioharvest.com (BHST)|Year-over-year net earnings per share growth for the last 12 months EXOZ|ORMP: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Entera Bio Ltd. (ENTX)|HYFT (MindWalk Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ABVC (ABVC BioPharma, Inc)|Year-over-year earnings per one share growth for the last 12 months CPIX|QNTM - Year-over-year earnings per share growth for the last twelve months|FibroGen Corp (FGEN) - Year-over-year net earnings per share growth for the last 12 months|Telomir Pharmaceuticals Corp (TELO) - Year-over-year earnings per share growth for the last twelve months|Rani Therapeutics (RANI) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Synergy CHC Corp.|Earnings per share growth in annualized terms for the last twelve months rallybio.com RLYB|Quarterly EPS earnings growth LEXX|PULM: Year-over-year net earnings per share trend for the last twelve months|Pheton Holdings Ltd - Year-over-year net earnings per share growth for the last 12 months|APM - Year-over-year net earnings per share growth for the last 12 months|LYRA - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months IBO (Impact BioMedical)|TNF Pharmaceuticals Inc. (TNFA) - Year-over-year earnings per share growth for the last twelve months|cbdMD Corp - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months PRFX|Altamira Therapeutics (CYTO) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth LIPO|Quarterly EPS earnings growth optinose.com (OPTN)|Year-over-year earnings per share growth for the last twelve months Pieris Pharmaceuticals, Inc. PIRS|Procaps (PROC) - Earnings per share growth in annualized terms for the last twelve months|PTPI - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Qilian International Corp QLI|SLRN: Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months TFFP (tffpharma.com)